ClinicalTrials.govpublic full text
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
advanced solid tumors, ly6e expression, topoisomerase i inhibitor (top1i), nsclc, breast cancer, gastric cancer, head and neck squamous cell carcinoma, ovarian cancer, pancreatic ductal adenocarcinoma, systemic antibody-drug conjugate therapy (adc) therapy, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876209
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.